Sfoglia per Autore
Analisi di polimorfismi in geni coinvolti nel ciclo dei folati come determinanti di suscettibilità a leucemia mieloide cronica.
2009 TURRINI E.; S. ANGELINI; S. SOVERINI; M. BACCARANI; G. CANTELLI FORTI; P. HRELIA
Biomarkers of susceptibility and effects in humans occupationally exposed to urban air pollution.
2009 ANGELINI S.; F. MAFFEI; R. KUMAR; F. CARBONE; E. TURRINI; G. CANTELLI FORTI; K. HEMMINKI; P. HRELIA
Association between genotypes and response to Imatinib mesylate treatment in a subset of previously untreated patients affected by gastrointestinal stromal tumours.
2009 ANGELINI S.; M. PANTALEO; E. TURRINI; G. CANTELLI FORTI; G. BIASCO; P. HRELIA
Association between transporters genotype and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the tops trial.
2009 ANGELINI S.; SOVERINI S.; TURRINI E.; PERINI G.; PANE F.; QUARANTELLI F.; HUGHES T.; WHITE D.; KIM D.W.; GOH H.; RADICH J.; BEPPU L.; SAGLIO G.; CILLONI D.; TERRAGNA C.; IACOBUCCI I.; HRELIA P.; CANTELLI FORTI G.; KALEBIC T.; THORNQUIST M.; BACCARANI M.; MARTINELLI G.
Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial.
2010 ANGELINI S.; S. POVERINI; E. TURRINI; G. PERINI; F. PANE; F. QUARANTELLI; T. HUGHES; D. WHITE; D.W. KIM; H. GOH; J. RADICH; L. BEPPU; G. SAGLIO; D. CILLONI; C. TERRAGNA; I. IACOBUCCI; P. HRELIA; G. CANTELLI FORTI; T. KALEBIC; M. THORNQUIST; M. BACCARANI; G. MARTINELLI
Association between genotypes and response to imatinib mesylate treatment in a subset of previously untreated patients affected by gastrointestinal stromal tumours.
2010 ANGELINI S.; M. PANTALEO; E. TURRINI; M. DI BATTISTA; G. CANTELLI FORTI; G. BIASCO; P. HRELIA
Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.
2011 Laechelt S;Turrini E;Ruehmkorf A;Siegmund W;Cascorbi I;Haenisch S
Mitochondrial pathway mediates the antileukemic effects of Hemidesmus Indicus, a promising botanical drug.
2011 FIMOGNARI C.; M. LENZI; L. FERRUZZI; E. TURRINI; P. SCARTEZZINI; F. POLI; R. GOTTI; A. GUERRINI; G. CARULLI; V. OTTAVIANO; G. CANTELLI FORTI; P. HRELIA
Multi-Target-Directed Drug Design Strategy: Development of new Naphthalene Diimides Bearing Isothiocyanate Functionality As Anticancer Agents
2012 V. Tumiatti; A. Milelli; C. Marchetti; L. Ferruzzi; M. Marton; E. Turrini; P. Hrelia; C. Fimognari; A. Minarini.
MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression.
2012 Turrini E;Haenisch S;Laechelt S;Diewock T;Bruhn O;Cascorbi I
Sulforaphane potentiates RNA damage induced by different xenobiotics.
2012 FIMOGNARI C.; M. LENZI; P. SESTILI; E. TURRINI; L. FERRUZZI; P. HRELIA; G. CANTELLI FORTI
Metabolic and toxicological considerations of botanicals in anticancer therapy.
2012 FIMOGNARI C.; L. FERRUZZI; E. TURRINI; G. CARULLI; M. LENZI; P. HRELIA; G. CANTELLI FORTI
Natural isothiocyanates: Genotoxic potential versus chemoprevention
2012 Fimognari C.; Turrini E.; Ferruzzi L.; Lenzi M.; Hrelia P.
Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality
2012 A. Minarini; A. Milelli; V. Tumiatti; L. Ferruzzi; M. R. Marton; E. Turrini; P. Hrelia; C. Fimognari
Exploiting RNA as a new biomolecular target for synthetic polyamines
2013 Minarini A.; Milelli A.; Tumiatti V.; Rosini M.; Lenzi M.; Ferruzzi L.; Turrini E.; Hrelia P.; Sestili P.; Calcabrini C.; Fimognari C.
Hemidesmus indicus induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line
2013 Ferruzzi L.; Turrini E.; Burattini S.; Falcieri E.; Poli F.; Mandrone M.; Sacchetti G.; Tacchini M.; Guerrini A.; Gotti R.; Hrelia P.; Cantelli-Forti G.; Fimognari C.
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
2013 Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G
Exploring the effects of isothiocyanates on chemotherapeutic drugs
2014 Anna Minarini; Andrea Milelli; Carmela Fimognari; Elena Simoni; Eleonora Turrini; Vincenzo Tumiatti
Natural compounds to overcome cancer chemoresistance: Toxicological and clinical issues
2014 Turrini, Eleonora; Ferruzzi, Lorenzo; Fimognari, Carmela
Determination of phytomarkers in pharmaceutical preparations of Hemidesmus indicus roots by micellar electrokinetic chromatography and high-performance liquid chromatography-mass spectrometry
2014 Jessica Fiori; Alberto Leoni; Carmela Fimognari; Eleonora Turrini; Patrizia Hrelia; Manuela Mandrone; Carmelina Iannello; Fabiana Antognoni; Ferruccio Poli; Roberto Gotti
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Analisi di polimorfismi in geni coinvolti nel ciclo dei folati come determinanti di suscettibilità a leucemia mieloide cronica. | TURRINI E.; S. ANGELINI; S. SOVERINI; M. BACCARANI; G. CANTELLI FORTI; P. HRELIA | 2009-01-01 | - | Società Italiana di Tossicologia | 4.02 Riassunto (Abstract) | - |
| Biomarkers of susceptibility and effects in humans occupationally exposed to urban air pollution. | ANGELINI S.; F. MAFFEI; R. KUMAR; F. CARBONE; E. TURRINI; G. CANTELLI FORTI; K. HEMMINKI; P. HRELIA | 2009-01-01 | - | European Environmental Mutagen Society | 4.02 Riassunto (Abstract) | - |
| Association between genotypes and response to Imatinib mesylate treatment in a subset of previously untreated patients affected by gastrointestinal stromal tumours. | ANGELINI S.; M. PANTALEO; E. TURRINI; G. CANTELLI FORTI; G. BIASCO; P. HRELIA | 2009-01-01 | - | Società Italiana di Farmacologia | 4.02 Riassunto (Abstract) | - |
| Association between transporters genotype and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the tops trial. | ANGELINI S.; SOVERINI S.; TURRINI E.; PERINI G.; PANE F.; QUARANTELLI F.; HUGHES T.; WHITE D.; KI...M D.W.; GOH H.; RADICH J.; BEPPU L.; SAGLIO G.; CILLONI D.; TERRAGNA C.; IACOBUCCI I.; HRELIA P.; CANTELLI FORTI G.; KALEBIC T.; THORNQUIST M.; BACCARANI M.; MARTINELLI G. | 2009-01-01 | - | Società Italiana di Tossicologia | 4.02 Riassunto (Abstract) | - |
| Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial. | ANGELINI S.; S. POVERINI; E. TURRINI; G. PERINI; F. PANE; F. QUARANTELLI; T. HUGHES; D. WHITE; D....W. KIM; H. GOH; J. RADICH; L. BEPPU; G. SAGLIO; D. CILLONI; C. TERRAGNA; I. IACOBUCCI; P. HRELIA; G. CANTELLI FORTI; T. KALEBIC; M. THORNQUIST; M. BACCARANI; G. MARTINELLI | 2010-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Association between genotypes and response to imatinib mesylate treatment in a subset of previously untreated patients affected by gastrointestinal stromal tumours. | ANGELINI S.; M. PANTALEO; E. TURRINI; M. DI BATTISTA; G. CANTELLI FORTI; G. BIASCO; P. HRELIA | 2010-01-01 | - | European Science Foundation | 4.02 Riassunto (Abstract) | - |
| Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. | Laechelt S;Turrini E;Ruehmkorf A;Siegmund W;Cascorbi I;Haenisch S | 2011-01-01 | PHARMACOGENOMICS JOURNAL | - | 1.01 Articolo in rivista | - |
| Mitochondrial pathway mediates the antileukemic effects of Hemidesmus Indicus, a promising botanical drug. | FIMOGNARI C.; M. LENZI; L. FERRUZZI; E. TURRINI; P. SCARTEZZINI; F. POLI; R. GOTTI; A. GUERRINI; ...G. CARULLI; V. OTTAVIANO; G. CANTELLI FORTI; P. HRELIA | 2011-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | PLoSOne.pdf |
| Multi-Target-Directed Drug Design Strategy: Development of new Naphthalene Diimides Bearing Isothiocyanate Functionality As Anticancer Agents | V. Tumiatti; A. Milelli; C. Marchetti; L. Ferruzzi; M. Marton; E. Turrini; P. Hrelia; C. Fimognar...i; A. Minarini. | 2012-01-01 | - | SN | 4.03 Poster | - |
| MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression. | Turrini E;Haenisch S;Laechelt S;Diewock T;Bruhn O;Cascorbi I | 2012-01-01 | PHARMACOGENETICS AND GENOMICS | - | 1.01 Articolo in rivista | - |
| Sulforaphane potentiates RNA damage induced by different xenobiotics. | FIMOGNARI C.; M. LENZI; P. SESTILI; E. TURRINI; L. FERRUZZI; P. HRELIA; G. CANTELLI FORTI | 2012-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | - |
| Metabolic and toxicological considerations of botanicals in anticancer therapy. | FIMOGNARI C.; L. FERRUZZI; E. TURRINI; G. CARULLI; M. LENZI; P. HRELIA; G. CANTELLI FORTI | 2012-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.01 Articolo in rivista | - |
| Natural isothiocyanates: Genotoxic potential versus chemoprevention | Fimognari C.; Turrini E.; Ferruzzi L.; Lenzi M.; Hrelia P. | 2012-01-01 | MUTATION RESEARCH. REVIEWS IN MUTATION RESEARCH | - | 1.01 Articolo in rivista | - |
| Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality | A. Minarini; A. Milelli; V. Tumiatti; L. Ferruzzi; M. R. Marton; E. Turrini; P. Hrelia; C. Fimognari | 2012-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Exploiting RNA as a new biomolecular target for synthetic polyamines | Minarini A.; Milelli A.; Tumiatti V.; Rosini M.; Lenzi M.; Ferruzzi L.; Turrini E.; Hrelia P.; Se...stili P.; Calcabrini C.; Fimognari C. | 2013-01-01 | GENE | - | 1.01 Articolo in rivista | - |
| Hemidesmus indicus induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line | Ferruzzi L.; Turrini E.; Burattini S.; Falcieri E.; Poli F.; Mandrone M.; Sacchetti G.; Tacchini ...M.; Guerrini A.; Gotti R.; Hrelia P.; Cantelli-Forti G.; Fimognari C. | 2013-01-01 | JOURNAL OF ETHNOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy | Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White... DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G | 2013-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 26°Haematol 98(2) 2013-1°Nome.pdf |
| Exploring the effects of isothiocyanates on chemotherapeutic drugs |
Anna Minarini; Andrea Milelli; Carmela Fimognari; Elena Simoni; Eleonora Turrini; Vincenzo Tumiatti |
2014-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.01 Articolo in rivista | - |
| Natural compounds to overcome cancer chemoresistance: Toxicological and clinical issues | Turrini, Eleonora; Ferruzzi, Lorenzo; Fimognari, Carmela | 2014-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.01 Articolo in rivista | - |
| Determination of phytomarkers in pharmaceutical preparations of Hemidesmus indicus roots by micellar electrokinetic chromatography and high-performance liquid chromatography-mass spectrometry | Jessica Fiori; Alberto Leoni; Carmela Fimognari; Eleonora Turrini; Patrizia Hrelia; Manuela Mandr...one; Carmelina Iannello; Fabiana Antognoni; Ferruccio Poli; Roberto Gotti | 2014-01-01 | ANALYTICAL LETTERS | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile